Coiled Therapeutics Commences Trading on AIM After Raising £8.5 Million

AI Summary

Coiled Therapeutics has officially started trading on the AIM market following a successful capital raise of £8.5 million. This funding aims to support the company's ongoing research and development initiatives. The initiation of trading marks a significant step for Coiled Therapeutics, which could impact investor perception in the biotech sector. Such fundraising events often influence stock liquidity and market participation.